Brativnyk A, Ankill J, Helland Å, Fleischer T(2024) Multi-omics analysis reveals epigenetically regulated processes and patient classification in lung adenocarcinoma Int J Cancer(in press) DOI 10.1002/ijc.34915, PubMed 38489486
Haakensen VD, Öjlert ÅK, Thunold S, Farooqi S, Nowak AK, Chin WL, Grundberg O, Szejniuk WM, Cedres S, Sørensen JB, Dalen TS, Lund-Iversen M, Bjaanæs M, Helland Å(2024) UV1 telomerase vaccine with ipilimumab and nivolumab as second line treatment for pleural mesothelioma - A phase II randomised trial Eur J Cancer, 202, 113973(in press) DOI 10.1016/j.ejca.2024.113973, PubMed 38447379
Nilssen Y, Brustugun OT, Fjellbirkeland L, Helland Å, Møller B, Wahl SGF, Solberg S(2024) Distribution and characteristics of malignant tumours by lung lobe BMC Pulm Med, 24(1), 106 DOI 10.1186/s12890-024-02918-w, PubMed 38439038
